Integrative Oncology · Resveratrol Research

Resveratrol and Cancer: Natural Polyphenol Research and Personalized Care

Resveratrol is a plant polyphenol found in grape skins, berries, peanuts and Japanese knotweed. It has become one of the most widely studied natural compounds in cancer biology because it may influence inflammation, redox signaling, cellular metabolism, epigenetics and cell-cycle control.

At Sunridge Medical, we translate that promising biology into an individualized discussion of formulation, exposure, treatment timing and goals. Human studies have already demonstrated that resveratrol can reach colorectal tissue and influence selected cancer-related biomarkers—encouraging foundations for more personalized integrative research.

Natural-compound expertiseFormulation personalizedClinical goals measured

Request a Cancer Consultation →Call 1-800-923-7878

Resveratrol molecular model, grape skins and chromatography analysis in a cancer research laboratory — Resveratrol connects natural-medicine tradition with modern research into inflammation, metabolism, epigenetics and cancer-cell signaling.

Resveratrol consultation

Review Resveratrol Dose, Form and Treatment Interactions

Laboratory research does not make every resveratrol product clinically equivalent. A physician can review the goal, dose, formulation, bleeding risk, medications and oncology treatment.

Human evidence is distinguished from laboratory findings
Formulation, dose and interaction risks are reviewed
Call now for an immediate response from our Patient Care Team

Call 1-800-923-7878 →

Resveratrol consultation

Speak With Our Patient Care Team

Share your diagnosis, active treatment and the resveratrol product you are considering.

* Required fields

Prefer to speak with someone now?

1-800-923-7878

Human evidence is distinguished from laboratory findings
Formulation, dose and interaction risks are reviewed
Questions before scheduling are always welcome

Resveratrol · Key Points

Why Resveratrol Inspires Integrative Research

Research

Extensive anticancer biology

Resveratrol affects multiple cancer-related pathways in cells and animals, creating a rich foundation for clinical translation.

Human Evidence

Biologic activity has reached patients

Presurgical colorectal and breast-risk studies documented tissue exposure and favorable biomarker changes.

Formulation

Delivery creates new possibilities

Because oral resveratrol is rapidly metabolized, micronized and physician-directed formulations are being explored to improve exposure.

Personalization

Dose and context can be tailored

Medication review, organ function and treatment timing help build a purposeful, patient-specific strategy.

Why Researchers Remain Interested

A Natural Compound With Many Potential Targets

Inflammation

NF-κB and inflammatory signaling

Preclinical work suggests resveratrol may modulate pathways that influence proliferation, survival and the tumor microenvironment.

Cell Cycle

Growth arrest and apoptosis

Cell models report changes in cell-cycle control and programmed cell death, supporting continued formulation research.

Metabolism

AMPK, sirtuins and IGF signaling

Human dosing studies have changed selected metabolic and circulating biomarkers relevant to cancer research.

Epigenetics

Gene regulation and methylation

A randomized breast-risk trial connected serum exposure with a favorable change in RASSF1A methylation.

One natural compound can influence several pathways

Resveratrol’s activity varies by dose, tissue, formulation, timing and cellular environment. That complexity gives experienced integrative physicians several ways to personalize its role.

Clinical Translation

Encouraging Findings From Human Cancer Research

In a presurgical study, 20 people with colorectal cancer took 0.5 or 1 gram of oral resveratrol daily for eight days. Resveratrol and its metabolites reached colorectal tissue, and tumor Ki-67 proliferation staining decreased by about 5%—an encouraging demonstration of tissue exposure and biologic activity in people.

An eight-patient phase I pilot found that a resveratrol-containing grape preparation influenced Wnt target-gene expression in normal colonic mucosa. In 39 women at increased breast-cancer risk, trans-resveratrol produced a favorable change in a tumor-suppressor methylation marker. These studies give researchers practical human signals to build upon.

Formulation & Route

Better Delivery May Expand Resveratrol’s Potential

Human pharmacokinetic studies show that oral resveratrol is well absorbed and then rapidly transformed into sulfate and glucuronide metabolites. This has inspired micronized, enhanced-bioavailability and physician-directed delivery strategies designed to create more useful exposure.

Micronization increased measured resveratrol exposure 3.6-fold in a small phase I study involving patients with colorectal-cancer liver metastases. Oral and IV approaches offer different possibilities, so Sunridge physicians can select the preparation, dose, sterility standards and monitoring plan around the individual goal.

Clinical opportunity: Formulation science can help bridge natural-compound research and practical integrative care. Better exposure is most useful when paired with clear goals and careful measurement.

Personalized Dosing & Coordination

Use Resveratrol’s Biological Activity Thoughtfully

Oncology physician and pharmacist reviewing resveratrol supplement timing with a cancer patient — A coordinated review helps patients receive the potential benefits of natural compounds with the right formulation, timing and monitoring.

Record the source, trans-resveratrol content, dose, route and complete ingredient list
Coordinate chemotherapy, targeted therapy, immunotherapy and radiation timing
Review anticoagulants, antiplatelet drugs and planned procedures
Use kidney and liver function to guide dose and formulation
Support gastrointestinal comfort and hydration at higher oral doses
Consider CYP3A4, CYP2D6, CYP2C9 and CYP1A2 interaction potential
Track patient-specific symptoms, laboratory values and treatment goals

Because very high-dose micronized resveratrol created kidney concerns in a multiple-myeloma study, Sunridge can use formulation-specific dosing and organ monitoring to keep a natural-medicine strategy appropriately individualized.

Physician-Directed Integrative Care

Build a Measurable Resveratrol Strategy

Start with pathology, stage, biomarkers and prior treatment response
Define whether the goal is prevention, metabolic support, symptom support or experimental tumor-directed use
Choose a formulation whose dose and exposure can be documented
Review interactions before—not after—combining it with cancer treatment
Establish baseline symptoms, blood counts and organ function
Reassess benefit, toxicity and continued relevance on a set schedule

NCI advises patients to discuss supplements with the cancer care team because foods and supplements may change drug absorption, metabolism or elimination. Coordination makes room for thoughtful natural therapies while protecting treatments with established benefit.

Sunridge Medical Approach

Bring Promising Natural Research Into a Complete Cancer Plan

Resveratrol is a biologically active natural compound with abundant preclinical research and informative human biomarker studies. Its many potential targets and evolving delivery strategies make it a strong candidate for the kind of personalized thinking that defines integrative oncology.

Our physicians can evaluate where resveratrol fits, whether another natural or IV therapy complements the same goal, and which measures will show progress. Patients are welcome before treatment, during treatment, at recurrence or with Stage 4 disease.

Frequently Asked Questions

Resveratrol and Cancer Questions

What is resveratrol?

It is a plant polyphenol found in grape skins, berries, peanuts and Japanese knotweed and available in concentrated formulations.

Why is resveratrol studied in cancer?

It influences inflammation, metabolism, epigenetics, cell-cycle control and apoptosis across a large body of experimental research.

Has resveratrol been tested in people with cancer?

Yes. Early colorectal studies demonstrated tissue exposure and favorable changes in selected proliferation and signaling biomarkers.

Why does formulation matter?

Resveratrol is absorbed and rapidly transformed into metabolites, creating opportunities for micronized and physician-directed delivery strategies.

What is promising about micronized resveratrol?

In a phase I study, micronization increased measured exposure 3.6-fold compared with previously published nonmicronized dosing.

Why might IV resveratrol be considered?

IV delivery offers a different exposure pathway that can be formulated and monitored around an individualized integrative goal.

Can resveratrol be coordinated with cancer drugs?

Yes. Because higher doses may affect drug-metabolizing enzymes, the exact medication list and timing should guide the plan.

How is bleeding risk handled?

Physicians review anticoagulants, antiplatelet drugs and procedure schedules and can adjust dose and timing accordingly.

Who benefits most from personalized monitoring?

Patients with kidney concerns, bleeding risk, hormone-sensitive disease, multiple medications or planned procedures especially benefit from coordination.

How would Sunridge evaluate resveratrol?

We review the cancer, treatment plan, formulation, dose, interactions, laboratory values and measurable clinical goal.

Primary Sources & Clinical Guidance

References

This page is educational and does not replace oncology advice. Resveratrol evidence and risk vary by source, dose, formulation, route and treatment context.

Considering Resveratrol During Cancer Care?

Match the Natural Compound to the Evidence, Treatment and Whole Patient

Our Patient Care Team can help determine which records, laboratory results and product details are needed for a physician-directed review of resveratrol formulation, interactions, organ safety, treatment timing and realistic goals.

Request a Cancer Consultation →Call 1-800-923-7878

Living research library · positive published findings

Research organized by cancer type

Browse 45 source-linked studies with the full title, publication year, research focus and a concise finding. Select any linked cancer type to move directly to its corresponding Sunridge page.

Search the library

Cancer type

Bone cancer

Multiple Effects of Resveratrol on Osteosarcoma Cell Lines.

2022 · Metastasis and invasion

We found (1) a cell growth inhibition due to an increase in cell distress, which was, in part, due to the involvement of the AKT and caspase-3 pathways, (2) an increase in cellular differentiation due to major gene expression levels of the osteoblastic differentiation genes, (3) an inhibition of IL-6 secretion due to an epigenetic effect on the IL-6 promoter, and (4) an inhibition of OS cells migration related to the decrease in IL-8 secretion levels due to an epigenetic effect on its promoter.

Find the right place to begin

Conditions & Care

Treatments & Therapies

Plan Your Care

Cancer care that happens here

Start Here

Cancers We Treat

Treatment & Planning

Find the right place to begin

Conditions & Care

Treatments & Therapies

Plan Your Care

Cancer care that happens here

Start Here

Cancers We Treat

Treatment & Planning

Resveratrol and Cancer: Natural Polyphenol Research and Personalized Care

Review Resveratrol Dose, Form and Treatment Interactions

Speak With Our Patient Care Team

Why Resveratrol Inspires Integrative Research

Extensive anticancer biology

Biologic activity has reached patients

Delivery creates new possibilities

Dose and context can be tailored

A Natural Compound With Many Potential Targets

NF-κB and inflammatory signaling

Growth arrest and apoptosis

AMPK, sirtuins and IGF signaling

Gene regulation and methylation

One natural compound can influence several pathways

Encouraging Findings From Human Cancer Research

Better Delivery May Expand Resveratrol’s Potential

Use Resveratrol’s Biological Activity Thoughtfully

Build a Measurable Resveratrol Strategy

Bring Promising Natural Research Into a Complete Cancer Plan

Resveratrol and Cancer Questions

References

Match the Natural Compound to the Evidence, Treatment and Whole Patient

Research organized by cancer type

Multiple Effects of Resveratrol on Osteosarcoma Cell Lines.

RETRACTION: Resveratrol Derivative, Trans-3, 5, 4'-Trimethoxystilbene Sensitizes Osteosarcoma Cells to Apoptosis via ROS-Induced Caspases Activation.

Effect of gold-conjugated resveratrol nanoparticles on glioma cells and its underlying mechanism.

Resveratrol as a Novel YAP Inhibitor Targeting Glioblastoma Progression and Sensitizing to Chemotherapy.

Resveratrol in Cancer Treatment with a Focus on Breast Cancer.

Resveratrol and Cervical Cancer: A New Therapeutic Option.

Resveratrol binds and activates RKIP protein in colorectal cancer.

Resveratrol restrains colorectal cancer metastasis by regulating miR-125b-5p/TRAF6 signaling axis.

Resveratrol induces apoptosis in human esophageal carcinoma cells.

Resveratrol Decreases the Invasion Potential of Gastric Cancer Cells.

Resveratrol induces apoptosis in SGC-7901 gastric cancer cells.

Resveratrol inhibits TGF-β1-induced EMT in gastric cancer cells through Hippo-YAP signaling pathway.

Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer.

Resveratrol targets mitochondrial USP36-SOD2 to induce autophagy-ferroptosis and inhibit gastric cancer progression.

Effect and mechanism of resveratrol on ferroptosis mediated by p53/SLC7A11 in oral squamous cell carcinoma.

Effects of resveratrol and irradiation upon oral squamous cell carcinoma cells.

Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro.

Resveratrol Induces Mitochondrial Apoptosis and Inhibits Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells.

Resveratrol Inhibits Nasopharyngeal Carcinoma (NPC) by Targeting the MAPK Signaling Pathway.

Resveratrol Inhibits Proliferation and Induces Autophagy by Blocking SREBP1 Expression in Oral Cancer Cells.

Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway.

Resveratrol suppresses malignant progression of oral squamous cell carcinoma cells by inducing the ZNF750/RAC1 signaling pathway.

Resveratrol synergistically enhances the effect of etoposide in HNSCC cell lines.

The antitumor effect of resveratrol on nasopharyngeal carcinoma cells.

Zeb1 for RCP-induced oral cancer cell invasion and its suppression by resveratrol.

Resveratrol enhances chemosensitivity of renal cell carcinoma to paclitaxel.

Resveratrol enhances sensitivity of renal cell carcinoma to tivozanib: An in-vitro study.

Involvement of Sphingolipid Metabolism Enzymes in Resveratrol-Mediated Cytotoxicity in Philadelphia-Positive Acute Lymphoblastic Leukemia.

Efficacy of resveratrol against breast cancer and hepatocellular carcinoma cell lines.

Evaluation of 3-O-β-D-galactosylated resveratrol-loaded polydopamine nanoparticles for hepatocellular carcinoma treatment.

In vivo mechanisms of resveratrol liposomes in targeting the TLR4/NLRP3 pathway in lung cancer.

Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung Cancer.

Epigenetic Regulation of Apoptosis in Cutaneous T-Cell Lymphoma: Implications for Therapy with Methotrexate, Jak Inhibitors, and Resveratrol.

Resveratrol-loaded nanocapsules inhibit murine melanoma tumor growth.

Resveratrol: A New Potential Therapeutic Agent for Melanoma?

Octreotide-functionalized and resveratrol-loaded unimolecular micelles for targeted neuroendocrine cancer therapy.

Resveratrol reduces lactate production and modifies the ovarian cancer immune microenvironment.

RETRACTION NOTICE: Curcumin and resveratrol inhibit chemoresistance in cisplatin-resistant epithelial ovarian cancer cells via targeting P13K pathway.

Resveratrol binds and inhibits transcription factor HIF-1α in pancreatic cancer.

Resveratrol inhibits pancreatic cancer proliferation and metastasis by depleting senescent tumor-associated fibroblasts.

Quercetin-Resveratrol Combination for Prostate Cancer Management in TRAMP Mice.

Mechanism of cancer-associated fibroblast-driven thyroid cancer dedifferentiation via the ZFP57-PKM2 axis-mediated lactate secretion and therapeutic intervention with resveratrol.